| Product Name | MF | CAS | Details |
|---|
| Glimepiride Impurity 11 | C24H34N4O5S | Details |
| Glimepiride Impurity 13 | C24H34N4O5S | Details |
| Etoposide Impurity 15 | Details |
| Etoposide Impurity 14 | Details |
| Etoposide Impurity 8 | Details |
| Etoposide Impurity 7 | C36H30O12 | Details |
| Glimepiride Impurity 16 | C24H34N4O5S | Details |
| Exemestane Impurity J | Details |
| Exemestane Impurity H | Details |
| Febuxostat Impurity 62 | C14H13NO4S | Details |
| Dextrorotation lansoprazole Impurity 11 | Details |
| Dexmedetomidine Impurity A | Details |
| Glimepiride Impurity 12 | C16H20N2O2 | Details |
| Glimepiride Impurity 14 | C24H34N4O5S | Details |
| Fludarabine Isome L | Details |
| Glimepiride Impurity 18 | C24H34N4O5S | Details |
| Glimepiride Impurity 10 | C24H34N4O6S | Details |
| Etoposide Impurity 10 | Details |
| Enzalutamide PO | Details |
| Etoposide Hydroxy isomer | Details |
| Enzalutamide Open - loop impurity | Details |
| Etoposide Impurity 9 | C28H26O8 | Details |
| Etoposide Impurity 13 | Details |
| Etoposide Impurity 19 | Details |
| Etoposide Impurity 16 | Details |
| Etoposide Impurity 17 | Details |
| Etoposide Impurity 18 | Details |
| Etoposide Impurity 11 | Details |
| Etoposide Impurity 12 | Details |
| Clozapine N-oxide | C18H19ClN4O | 34233-69-7 | Details |
| Dabigatran Impurity 20 | C27H30ClN7O3 | Details |
| Dabigatran Impurity 21 | Details |
| Glimepiride Impurity 2 | C15H28N2O | Details |
| Glimepiride Impurity 17 | C24H34N4O5S | Details |
| Glimepiride Impurity 19 | C8H13NO | Details |
| Glimepiride Impurity 15 | C24H34N4O5S | Details |
| Glimepiride Impurity 20 | C24H34N4O5S | Details |
| Glyburide impurity A | Details |
| Glimepiride Impurity 1 | C24H34N4O5S | Details |
| Etoposide Impurity S | Details |
| Exemestane Impurity I | Details |
| Etoposide Impurity Z | Details |
| Fludarabine EP impurity A | C10H14N5O8P | Details |
| Glimepiride Impurity 4 | C24H34N4O5S | Details |
| Glimepiride Impurity 3 | C24H34N4O5S | Details |
| Clindamycin phosphate Impurity K | Details |
| Demiditraz Impurity 5 | C13H16N2 | 944263-08-5 | Details |
| Dextrorotation lansoprazole-N-oxide | Details |
| Exemestane Impurity D | C6H12O | Details |
| Glyburide impurity B | Details |
| Lansoprazole IMpurity K | Details |
| Lansoprazole IMpurity L | Details |
| Lansoprazole IMpurity J | Details |
| Lansoprazole IMpurity I | Details |
| Lansoprazole IMpurity M | Details |
| Etoposide Impurity 6 | Details |
| Fludarabine EP impurity J | Details |
| Doxofylline Impurity A | Details |
| Etoposide Impurity B | C29H32O13 | Details |
| Etoposide Impurity 4 | C35H32Cl6O16 | Details |
| Etoposide Impurity 1 | Details |
| Etoposide Impurity D | C27H30O13 | Details |
| Etoposide Impurity C | C29H32O13 | 100007-53-2 | Details |
| Cycloserine Impurity 1 | C3H6N2O2 | 339-72-0 | Details |
| Etoposide Impurity E | C21H20O8 | Details |
| Etoposide Impurity 5 | Details |
| Etoposide Impurity 3 | Details |
| Etoposide Impurity 2 | Details |
| Duloxetine IMpurity 11 | C8H11NO2S | Details |
| Dabigatran carbyne Impurity 28 | C8H10N2O2 | 66315-15-9 | Details |
| Dabigatran Impurity 19 | C16H12N4O | 1900865-84-0 | Details |
| Dabigatran Etexilate iMpurity 23 | C7H13ClO2 | Details |
| Dabigatran Etexilate iMpurity 24 | C38H49N7O5 | Details |
| Dabigatran Impurity R | C25H26N8O2 | 1643377-48-3 | Details |
| Dabigatran Impurity 27 | C41H55N7O8 | 1643392-59-9 | Details |
| Dabigatran Etexilate iMpurity 26 | Details |
| Dabigatran Impurity 35 | C7H13ClO2 | 58906-62-0 | Details |
| Exemestane Impurity E | C20H24O3 | 152764-24-4 | Details |
| Exemestane Impurity G | C20H24O3 | 152764-31-3 | Details |
| Fasudil N-Hydroxy Impurity | C14H17N3O3S | 1350827-92-7 | Details |
| Fasudil Dimer | C23H22N4O4S2 | 1337967-93-7 | Details |
| Fludarabine EP impurity F | C12H18N5O8P | 159002-28-5 | Details |
| Fludarabine EP impurity D | C5H4FN5 | 700-49-2 | Details |
| Fludarabine EP impurity I | C10H15N6O7P | 7561-54-8 | Details |
| Fludarabine EP impurity C | C10H14FN5O10P2 | 548774-53-4 | Details |
| Fludarabine EP impurity B | C5H5N5O | 149297-79-0 | Details |
| (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl) | C10H12FN5O4 | 21679-14-1 | Details |
| ((2R,3S,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl) | Details |
| Clavulanic acid Impurity M | C8H20N2O | 3033-62-3 | Details |
| Clavulanic acid Impurity L | C8H20N2 | 4013-94-9 | Details |
| Baricitinib Impurity I | C10H8O | 90-15-3 | Details |
| 116539-60-7;(R)-N-methyl-3-(naphthalen-1-yloxy) | C18H20ClNOS | 910138-96-4 | Details |
| (R)-N,N-dimethyl-3-(naphthalen-1-yloxy) | C19H21NOS | 878757-08-5 | Details |
| Duloxetine impurity G | C10H7F | 321-38-0 | Details |
| Duloxetine EP impurity F | C18H19NOS | 959392-22-4 | Details |
| (S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol | C9H15NOS | 1384080-56-1 | Details |
| (R)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol | C8H13NOS | 116539-57-2 | Details |
| Duloxetine IMpurity 19 | C19H21NOS | 1384080-33-4 | Details |
| 1-methyl-12-thioxobenzo[4',5']imidazo | Details |
| 1,3-dimethyl-6,7,9,10-tetrahydro-7,10 | C11H16N4O4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 | ||||